drugset / Trial / NCT04266509
Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600
RandomizedSequentialOpen-labelBasic science
Summary
Study to Evaluate the Effect of Repeat-Dose Rifampin on the pharmacokinetics (PK) of PF-06651600.
Timeline
- Start
- 2020-06-25
- Primary completion
- 2020-09-10
- Completion
- 2020-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritlecitinib | Small molecule | 50 mg | Oral |
| Background | Rifampin | Small molecule | 600 mg | — |
Indications
No indication recorded.